MORGAN STANLEY PLC/CALL/SANOFI/130/0.1/20.12.24 Share Price

Warrant

DE000ME5YNH6

Market Closed - Börse Stuttgart 11:41:05 07/06/2024 pm IST
0.019 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/SANOFI/130/0.1/20.12.24
Current month+11.76%
1 month-45.71%
Date Price Change
07/24/07 0.019 0.00%
06/24/06 0.019 +5.56%
05/24/05 0.018 0.00%
04/24/04 0.018 -5.26%
03/24/03 0.019 +11.76%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 11:41 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
Issuer Morgan Stanley
WKN ME5YNH
ISINDE000ME5YNH6
Date issued 28/12/2023
Strike 130
Maturity 20/12/2024 (195 Days)
Parity 10 : 1
Emission price 0.09
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.134
Lowest since issue 0.011
Spread 0.02
Spread %50.00%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
91.13 EUR
Average target price
108.2 EUR
Spread / Average Target
+18.72%
Consensus